ProQR Therapeutics N.V.

PRQR chart

ProQR Therapeutics N.V. news

• ProQR Therapeutics N.V. Estimates – NASDAQ:PRQR

  TradingView · Oct 23, 10:26 AM EDT

• ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease

  marketbeat.com · Oct 2, 4:02 AM EDT

• ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

  Yahoo Finance · Sep 23, 8:00 AM EDT

• ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

  Yahoo Finance · Sep 9, 8:00 AM EDT

• ProQR to Participate in Upcoming Investor Conferences in September 2026

  Yahoo Finance · Sep 2, 8:00 AM EDT

• Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

  Yahoo Finance · Aug 14, 8:25 AM EDT

• ProQR Announces Second Quarter 2026 Operating and Financial Results

  Yahoo Finance · Aug 13, 7:00 AM EDT

• ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

  Yahoo Finance · Jun 25, 6:35 AM EDT

• ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

  Yahoo Finance · Jun 25, 6:25 AM EDT

• Undervalued Penny Stocks To Consider In June 2026

  Yahoo Finance · Jun 8, 8:05 AM EDT

• ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%

  Yahoo Finance · May 14, 8:25 AM EDT

• ProQR Announces First Quarter 2026 Operating and Financial Results

  Yahoo Finance · May 12, 7:00 AM EDT

ProQR Therapeutics N.V. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-09-23
• 6-KFORM 6-K2026-09-09
• 6-K6-K2026-08-13
• 6-KFORM 6-K2026-08-13
• 6-KFORM 6-K2026-06-26
• 6-KFORM 6-K2026-06-25
• 6-KFORM 6-K2026-06-02
• 6-K6-K2026-05-12
• 6-KFORM 6-K2026-05-12
• 6-KFORM 6-K2026-05-04
• 6-KFORM 6-K2026-04-30
• 6-KFORM 6-K2026-04-08

About ProQR Therapeutics N.V.

Ticker

PRQR (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Leiden

Incorporated in

Netherlands

Fiscal year end

December 31

SEC CIK

1612940

Former names

ProQR Therapeutics B.V.

Frequently asked questions